ClinicalTrials.govpublic full text
18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
breast cancer, chemotherapy, cdk4/6 inhibitors, 18f-fluoroestradiol (18f-fes) pet/ct, hr positive, her2 negative, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981629
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.